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Abstract
The chapter is devoted to study the effects of astaxanthin on the frequency of chromosomal 
aberrations and the level of DNA damages in human peripheral blood lymphocytes under 
ionizing radiation exposure in vitro. To achieve the purpose of the research, a combination 
of classical cytogenetic methods (G
0
- and G
2
-radiation sensitivity assays) and method of 
single-cell electrophoresis (comet assay) was used. The specificity of the modifying effect 
of astaxanthin on radiation-induced genomic injuries depending on the stage of the cell 
cycle had been determined. Significant weakening of the negative effect of ionizing radia-
tion on the G
0
 stage and the absence of a radioprotective effect on the S and G
2
 stages of 
the cell cycle may be associated with activation by astaxanthin of apoptosis in irradiated 
cells with a critically high level of the genome damages. The research results not only tes-
tify about strong radioprotective effect of astaxanthin but also demonstrate the feasibility 
of the parallel use of cytogenetic and molecular genetic methods to assess the impact as 
mutagens as well as factors that modify the effect of mutagens on genome stability.
Keywords: astaxanthin, lymphocytes, γ-radiation, DNA breaks, chromosomal 
aberrations
1. Introduction
The ecological situation that arose from nuclear accidents in Chornobyl and Fukushima, con-
stant expansion of usage of the ionizing radiation in industry and medicine, and the threats 
of nuclear terrorism especially aggravated in the last decade are risk factors for the growth of 
radiation burden on human populations. The abovementioned conditions require the search 
© 2018 The Author(s). Licensee IntechOpen. This chapter is distributed under the terms of the Creative
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for new safe and effective radioprotectors, preferably of natural origin, for prevention and 
treatment of radiation-induced damages in humans, especially which cause genome altera-
tions and cancer. For that purpose, carotenoids, due to its chemical and biological properties, 
are the most promising substances [1].
Astaxanthin is a carotenoid of xanthophyll group, and it is one of the most common red 
pigments of algae, yeasts, krill, shrimps, crayfish, trout, and salmon [2]. It is known that 
astaxanthin is the most powerful antioxidant, which has the ability to scavenge free radicals 
in tens of times higher than α-tocopherol or β-carotene [3], and has anti-inflammatory [2], 
immunomodulating [4], and anticarcinogenic [5–7] effects.
Since 2015, we have started the investigation of the radioprotective effects of astaxanthin 
studying parameters of genome damages in human somatic cells. In this chapter, we have 
concentrated on physicochemical properties of astaxanthin and its biological effects with 
the main focus on the data from our investigations concerning the impact of astaxanthin on 
radiation-induced genome damages in human somatic cells and have discussed eventual 
mechanisms of its action.
2. Physicochemical properties and peculiarities of biological action 
of astaxanthin
Astaxanthin is a secondary carotenoid, which belongs to the group of xanthophylls and has 
two additional oxygen atoms on each benzene ring in comparison with β-carotene. This gives 
astaxanthin a rich red color and greatly increases its antioxidant properties. Unlike β-carotene, 
astaxanthin is not a vitamin A precursor [8].
Empirical formula: C
40
H
52
O
4
Molar weight: 596.84 g/M
In contrast to primary carotenoids, which are associated with the structural and functional 
components of the photosynthetic apparatus, secondary carotenoids, which include astax-
anthin, are in the cell in oil droplets, and their main function is to form a protective layer to 
prevent the damages, which are provoked by stress conditions [9, 10].
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Because the astaxanthin molecule contains conjugated double bonds, hydroxyl and keto 
groups, it has both lipophilic and hydrophilic properties [11]. Astaxanthin has two chiral cen-
ters and can exist in three different stereoisomers—3S, 3′S; 3R, 3′S; and 3R, 3′R. The probability 
of obtaining these isomers of astaxanthin in the process of chemical synthesis is 1:2:1 [12, 13].
Nowadays natural astaxanthin mainly derived from microalgae (hyperproducer Haema­
tococcus pluvialis), yeast (Phaffia rhodozyma) and animal-consumers included a number of 
small marine crustaceans (Euphausiacea) and the salmon family (Salmonidae) [2]. Microalgae 
Haematococcus pluvialis produces astaxanthin mainly 3S, 3′S stereoisomeric form; precisely, 
such molecular structure is considered the most valuable [14].
As shown in experiments in vitro, astaxanthin effectively protects cells from nonspecific oxida-
tion by quenching singlet oxygen, effectively inhibits lipid peroxidation in biological samples, 
and owing to the capture of free radical prevents or stops the chain reaction of oxidation [2, 
15, 16]. In addition to direct protective effect, astaxanthin inhibits the activation of the H
2
O
2
-
mediated transcription of the factor NF-kB (the nuclear factor “kappa-b”—a universal tran-
scription factor) that controls the expression of heme oxygenase 1 (HMOX1), one of the markers 
of oxidative stress, and nitric oxide synthase (iNOS) [17, 18]. Astaxanthin blocks the cytokine 
production declined by modulating the expression of protein tyrosine phosphatase 1 [18].
Experiments on the determination of astaxanthin toxicity showed a high level of safety—LD
50
 
was not established after single administration of substance to rats. The studies confirmed the 
absence of histopathological changes and the dose-effect dependence upon oral administra-
tion of astaxanthin in doses ranging from 4.161–17.076 to 465.0–557.0 mg/kg per day [19].
The accumulated published data have shown the multifaceted positive effect of astaxanthin 
in mammals by reducing the manifestations of oxidative stress, including during inflamma-
tion processes; it can prevent the development of atherosclerotic cardiovascular diseases and 
participate in the regulation of lipid and glucose metabolism [19–23].
These properties of astaxanthin primarily attributed to its ability to exhibit activity both at the 
level of the cell membrane and in the area of the cytoplasm, thus affecting the flow of intracel-
lular processes [2]. Due to these unique properties, astaxanthin exhibits significantly higher 
biological activity in comparison with other antioxidants [24].
Thus, the above data indicate that astaxanthin complies with all the requirements that apply 
to radioprotectors (low toxicity, high antiradical and antioxidant activity, the ability to act 
both at the membrane level and in the intracellular space). These properties of astaxanthin 
suggest that it may have antimutagenic activity and, as consequence, radioprotective effect 
on the human genome.
3. Investigation of radioprotective properties of astaxanthin
Since 2015, we examined the possibility of modification by astaxanthin and the negative 
effects of ionizing radiation on the human blood lymphocyte genome in vitro. The decrease 
in the intensity of radiation-induced genome damages on the chromosomal and molecular 
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levels was selected as an indicator of radioprotective effect of astaxanthin. The studies were 
conducted using a combination of the methods of classical cytogenetic analysis (G
0
-radiation 
sensitivity assay and G
2
-radiation sensitivity assay) and the method of single-cell electropho-
resis (comet assay) [25–29].
The parallel application of two methodological approaches for such a study greatly expanded 
the experimental possibilities. Thus, due to cytogenetic methods, the state of the chromo-
somal apparatus of the cell (frequency of different types of chromosome aberrations) is clearly 
visualized starting from the 48 h of cultivation. The comet electrophoresis is highly sensitive 
and provides the ability to determine the relative levels of single- and double-strand DNA 
breaks in individual cell. When conducting cell electrophoresis, the DNA migrates into the 
agarose gel, forming a structure that resembles a comet (Figure 1), and the use of the comet 
assay can simultaneously estimate the effect of both mutagenic and antimutagenic factors 
on the stability of the human somatic cell genome, starting from 0 h of cultivation [30, 31]. In 
addition, the use of single-cell electrophoresis makes it possible to determine the effectiveness 
of the reparation systems and to assess the correctness of the operation of control mechanisms 
at checkpoints between all stages of the cell cycle (G
1
–S, S–G
2
, G
2
–M). Moreover, an important 
feature of the comet assay is the identification of cells in which the apoptosis program has 
begun or has already been implemented [32–34].
In cells with a lack or a low level of damages, the “tail” is formed also by the release of DNA 
loops into the gel. Because in the cell during realization of the apoptotic process genomic 
fragmentation of the high level occurs, a massive yield of DNA fragments into agarose gel is 
observed (Figure 1), and “comets” have the typical elongated “tail” part.
To quantify the migration of DNA into the agarose gel, two indices are used: the percentage of 
DNA in the “tails” and tail moment (TM). TM simultaneously which takes into account both the 
Figure 1. Examples of “comets” obtained in the experiment: (А, B, C) The “comets” arisen from cells with a low level of 
DNA breaks and (D) “atypical comet” (apoptotic cell) [28].
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amount of DNA and the length of the “tail” (TM = “tail” length multiplied by the percentage of 
DNA in the “tail”) is more informative and calculated automatically during the computer analysis.
3.1. The impact of astaxanthin on the level of radiation-induced chromosomal 
aberrations in human lymphocytes
To evaluate the possible mutagenic activity of astaxanthin, it was tested at concentrations of 
2.0, 10.0, 20.0, and 40.0 μg/ml in the culture of human peripheral blood lymphocytes. In the 
cytogenetic assay, it was found that the frequencies of aberrant cells and the levels of chromo-
somal aberrations under the astaxanthin exposure in vitro in all tested concentrations did not 
differ from the corresponding background cytogenetic parameters (p > 0.05) [25].
To determine the optimal working concentration of astaxanthin for further research of its 
radiomodifying capacity, a pilot study of its impact on the culture of human peripheral blood 
lymphocytes is exposed in vitro to gamma quanta in a dose of 1.0 Gy on G
0
 phase of the first 
mitotic cycle (Figure 2).
It is established that astaxanthin in all tested concentrations significantly (p < 0.01) reduced 
the frequencies of radiation-induced chromosome aberrations, but the effectiveness of its 
modifying action depended on its concentration in the irradiated culture.
The maximum radioprotective effect of astaxanthin (the most effective drop in the frequency 
of cytogenetic markers of radiation exposure) was observed after administration of astaxanthin 
before irradiation of cultures at concentrations of 20.0 and 40.0 μg/ml (7.69 ± 1.74 and 7.72 ± 1.80 
per 100 cells, respectively). These concentrations did not affect the mitotic activity of the lympho-
cyte culture, had no mutagenic effect on non-irradiated cells, and effectively (to ~ 70%) reduced 
the level of aberrant metaphases and the frequency of cytogenetic markers of radiation expo-
sure. So long as significant difference between the values that characterize carotenoid activity in 
these concentrations (p > 0.05) was not observed, for the further studies of the radiomodifying 
capacity of astaxanthin, the concentrations of 20.0 μg/ml were chosen.
Figure 2. Selection of the optimal concentration of astaxanthin to study its modifying effect on the γ-irradiated culture 
of human blood lymphocytes.
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To analyze the possible dependence of radioprotective properties of astaxanthin from the 
stage of the mitotic cycle on which the cells were exposed to ionizing radiation, lymphocyte 
cultures were irradiated at 0, 40, and 46 h, corresponding to G
0
, S, and G
2
 stages of the first cell 
cycle. Astaxanthin was added to cultures of lymphocytes at least an hour before irradiation. 
The obtained data are presented in the Table 1.
After irradiation of lymphocyte culture in a dose of 1.0 Gy on the G
0
 stage of the cell cycle, the 
effect of astaxanthin resulted in a significant reduction of the radiation-induced cytogenetic 
effect, namely, a decrease of almost in 3.5 times both the mean frequency of the aberrant 
metaphases and the level of chromosome aberrations—up to 7.82 ± 0.72% and 8.48 ± 0.75 per 
100 cells, respectively—and exclusively due to aberrations of chromosome type (Table 1). The 
antimutagenic activity of astaxanthin was characterized by significant (p < 0.001) decrease 
in the frequency of classical unstable cytogenetic markers of radiation exposure—dysenteric 
and ring chromosomes (up to 2.37 ± 0.41 and 0.43 ± 0.18 per 100 metaphases, respectively), 
as well as the total level of simple acentrics—free double fragments, and acentric rings (up to 
4.74 ± 0.62 per 100 metaphases) (Table 1, Figure 3).
In contrast to the modifying activity shown by astaxanthin in lymphocyte cultures irra-
diated on the G
0
 phase of the cell cycle, the addition of carotenoid on the G
2
 phase did 
not change as the total average frequency of radiation-induced chromosomal damages 
(72.35 ± 1.17 and 71.54 ± 1.34 per 100 metaphases, respectively, p > 0.05) as the spectrum of 
chromosome aberrations (Figure 4). Among chromosomal damages, dominated aberrations 
of chromatid type represented by single fragments and chromatid exchanges with the total 
average frequency 58.42 ± 1.47 per 100 metaphases did not differ from such (58.32 ± 1.34 
per 100 metaphases) in exposed cultures without adding astaxanthin. Aberrations of the 
chromosome type were mainly represented by free double fragments; the average group 
frequencies of it did not differ between themselves (13.12 ± 1.00 and 14.03 ± 0.91 per 100 
metaphases, respectively).
In much the same way, astaxanthin did not exhibit modifying effect on radiation-induced 
cytogenetic effects in lymphocyte cultures irradiated on the S stage of the cell cycle. The total 
mean group frequencies of radiation-induced chromosomal damages were 19.57 ± 1.11 and 
18.46 ± 1.15 per 100 metaphases in exposed cultures without and with the previous addition 
of astaxanthin, respectively. Among the chromosomal damages, simple aberrations prevailed 
(single and double fragments) in both variants of the experiment (Table 1, Figure 4).
Thus, due to the use of cytogenetic methods, the following important aspects of the astaxan-
thin modifying action were established:
1. The effectiveness of astaxanthin has a dependence on the stage of the cell cycle on which 
lymphocytes were irradiated.
2. The radioprotective effect of astaxanthin is realized in cells exposed only on G
0
 stage of the 
mitotic cycle which manifests in lowering the frequency of chromosome-type aberrations 
for the induction of which a large number of double-stranded DNA breaks as the error of 
repairing of such damages are needed, which permit to suggest the impact of carotenoid 
on cells with the high level of genomic instability.
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Frequency of 
the aberrant 
Metaphases
Chromosome 
aberrations 
(per 100 cell)
Frequency of chromosome aberrations
Chromatid type Chromosome type
Single 
fragments
Chromatid 
exchanges
Total Double 
fragments
Dysenteric Centric 
rings
Abnormal 
monocentric
Acentric 
rings
Total
Unirradiated 
culture
2.52 ± 0.34 2.57 ± 0.35 1.60 ± 0.28 0.00 1.60 ± 0.28 0.96 ± 0.21 0.00 0.00 0.01 ± 0.01 0.00 0.97 ± 0.22
G
0
(1.0 Gy)
22.93 ± 1.19 24.55 ± 1.22 1.54 ± 0.35 0.00 1.54 ± 0.35 6.47 ± 0.70 12.80 ± 0.95 2.76 ± 0.47 0.49 ± 0.20 0.49 ± 0.20 23.02 ± 1.20
G
0
(1.0 Gy + А)
7.82 ± 0.72 8.48 ± 0.75 0.72 ± 0.23 0.00 0.72 ± 0.23 4.67 ± 0.57 2.37 ± 0.41 0.43 ± 0.18 0.22 ± 0.13 0.07 ± 0.07 7.76 ± 0.71
S
(1.0 Gy)
18.30 ± 0.97 19.57 ± 1.11 7.94 ± 0.67 2.27 ± 0.33 10.21 ± 0.37 9.36 ± 0.67 0.00 0.00 0.00 0.00 9.36 ± 0.67
S
(1.0 Gy + А)
16.92 ± 1.12 18.46 ± 1.15 6.15 ± 0.67 2.30 ± 0.33 8.45 ± 0.67 10.01 ± 1.0 0.00 0.00 0.00 0.00 10.01 ± 1.0
G
2
 (1.0 Gy) 47.06 ± 1.31 72.35 ± 1.17 56.04 ± 1.30 2.28 ± 0.39 58.32 ± 1.29 13.76 ± 0.90 0.27 ± 0.51 0.00 0.00 0.00 14.03 ± 0.91
G
2
(1.0 Gy + А)
46.72 ± 1.48 71.54 ± 1.34 56.47 ± 1.47 1.95 ± 0.41 58.42 ± 1.47 12.94 ± 1.0 0.18 ± 0.41 0.00 0.00 0.00 13.12 ± 1.0
Table 1. Comparison of the mean group values of cytogenetic parameters in irradiated in vitro in dose 1.0 Gy human lymphocyte cultures on G
0
, S, and G
2
 stages of the 
cell cycle and under the joint action of γ-radiation and astaxanthin in concentration 20.0 μg/ml.
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3.2. The impact of astaxanthin on the level of DNA damages in human lymphocytes
For evaluation of the relative level of DNA damages (single- and double-strand DNA breaks), 
the method of single-cell gel electrophoresis (comet assay) in neutral condition was used. As a 
parameter of DNA breakage, the TM computed as the %DNA in the comet tail multiplied by 
the tail length was chosen. For comet assay, we used peripheral blood lymphocytes without 
Figure 4. Frequencies and spectra of radiation-induced chromosome aberrations under γ-radiation exposure in dose 
of 1.0 Gy in vitro and astaxanthin in concentration of 20.0 μg/ml on different stages of the cell cycle. G
0
, S, and G
2
 (cell 
cultures irradiated without astaxanthin) and G
0
 (A), S(A), and G
2
(A) (cell cultures irradiated with supplemented 20.0 μg/
ml astaxanthin).
Figure 3. Change in the frequency and spectrum of chromosome-type aberrations under joint action of astaxanthin in the 
concentration of 20.0 μg/ml and γ-radiation in a dose of 1.0 Gy on the G
0
 stage of the cell cycle.
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culturing (0 h) and from 48 human-PBL cultures. Some cultures were exposed to γ-ray (emit-
ter IBL-237C, dose rate 2.34 Gy/min) in dose 1.0 Gy at 0, 40, and 46 h of cultivation. Non-
irradiated cultures were used as experimental control. Those times were chosen by the reason 
that lymphocytes, which we can see after 48 h of cultivation on their metaphase stage, are at 
G
0
 (0 h), S (40 h), and G
2
 (46 h) phases of the cell cycle. Astaxanthin in the final concentration 
20.0 μg/ml, which was defined during our cytogenetic study, was added to the cultures of 
lymphocytes before irradiation.
Similarly to our cytogenetic data, no significant changes in DNA breakage were detected in 
non-irradiated samples supplemented with astaxanthin compared with untreated lympho-
cytes both after 0 and 48 h of cultivation (Table 2). This confirms our suggestion that astaxan-
thin in chosen concentration has no mutagenic activity.
As can be seen from the Table 2 and Figure 6, after γ-irradiation of lymphocytes in dose 
1.0 Gy at G
0
 phase of the cell cycle, significant increasing in TM was detected (from 2.80 ± 0.54 
to 6.55 ± 1.82, p < 0.05 and from 4.07 ± 0.60 to 12.86 ± 0.74, p < 0.05, after 0 and 48 h of cultiva-
tion, respectively).
The effect of astaxanthin on irradiated cells manifested in significant (р < 0.001) decrease in the 
average level of DNA damages in lymphocytes from cultures irradiated at G
0
 nearly to the value 
of non-irradiated control both after 0 and 48 h of cultivation (TM = 3.74 ± 0.82 and 5.27 ± 1.77, 
respectively) (Figure 5).
As expected, significant increase in the level of DNA breaks was detected in lymphocytes after 
γ-irradiation at 40 h of cultivation (Table 3). The mean value of TM was equal to 7.45 ± 0.36 in 
irradiated and 4.07 ± 0.60 in lymphocytes from intact cultures (p < 0.01). Astaxanthin in con-
centration 20 μg/ml significantly (p < 0.01) decreased the DNA damages in lymphocytes from 
cultures irradiated at 0 and 40 h of incubation nearly to the level of non-irradiated control 
(TM = 5.27 ± 1.77 and 4.79 ± 0.23, respectively). The treatment of cells with astaxanthin resulted 
in statistical significant decrease of radiation-induced DNA damages (TM = 3.21 ± 0.48, p < 0.05 
compared with irradiated samples) likewise after irradiation of lymphocytes at G
0
 phase of the 
cell cycle.
Similar results were obtained after treatment at 46 h of incubation (Table 4). Irradiation of 
lymphocyte cultures at G
2
 phase of the cell cycle led to a large amount of DNA breaks and, as 
outcome, to material increase in ТМ value (12.06 ± 1.88, p < 0.001). The effect of astaxanthin 
Treatment 0 h 48 h
Tail moment (X ± Se) Tail moment (X ± Se)
Control 2.80 ± 0.54 4.07 ± 0.60
Supplementation with astaxanthin 3.55 ± 1.37 5.93 ± 0.93
Irradiation 6.55 ± 1.82 12.86 ± 0.74
Table 2. The impact of γ-irradiation at G
0
 phase and astaxanthin supplementation on DNA damages in human lym-
phocytes after 0 and 48 h of cultivation.
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supplementation was somewhat not only weaker than in previous experiments but also 
significant compared to cultures irradiated on G
2
 stage (TM = 8.96 ± 2.39 and 12.06 ± 1.88, 
respectively, p < 0.05).
Treatment Tail moment
X ±Se
Control 4.07 0.60
Control + astaxanthin 5.93 0.93
Irradiation at S phase 7.45 0.36
Irradiation at S phase + astaxanthin 4.79 0.23
Notes: X, mean value; Se, standard error.
Table 3. The tail moment values in human blood lymphocytes after γ-radiation exposure and under combined action of 
radiation and astaxanthin at S phase of the cell cycle.
Treatment Tail moment
X ±Se
Control 4.07 0.60
Control + astaxanthin 5.93 0.93
Irradiation at G
2
 phase 12.06 1.88
Irradiation at G
2
 phase + astaxanthin 8.96 2.39
Notes: X, mean value; Se, standard error.
Table 4. The tail moment values in human blood lymphocytes after γ-radiation exposure and under combined action of 
radiation and astaxanthin at G
2
 phase of the cell cycle.
Figure 5. The relative levels of DNA damages irradiated at G
0
-phase human lymphocytes non-supplemented or 
supplemented with astaxanthin cultures.
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Our data suggested that astaxanthin decreased the rate of radiation-induced DNA breaks 
in human lymphocytes regardless of the phase of the cell cycle when the irradiation was 
performed. However, this conclusion is not consistent with our cytogenetic results: it was 
observed that astaxanthin is able to decrease frequency of radiation-induced chromosome 
aberration only if cells were irradiated at G
0
 phase of the cell cycle.
For more detailed analysis, we have studied the frequency distribution of individual cells 
depending on their levels of DNA damages. According to TM, the sampling of “comets” from 
control variants was divided into ten groups of 10% each. The established values of deciles 
(TMs were 0.81, 1.28, 1.81, 2.69, 3.80, 5.07, 6.48, 10.19, 15.98) were chosen as boundary indices 
to form ten groups of cells from irradiated cultures treated or not by astaxanthin and to esti-
mate percentage of “comets” that have TM within the appropriate range. If the value of TM 
was equal to the boundary index, then “comet” was referred to the next group. The results 
are shown on Figure 6.
When lymphocytes were irradiated at the G
0
 phase of the cell cycle, after 48 h of incubation, 
the increase in the average TM level was caused exclusively by growth of the frequency of 
the “comets” from the tenth group (TM > 15.98) (Figure 6A), which indicates accumulation 
of cells with a large number of DNA damages with time. Irradiation at the 40th hours of 
cultivation (Figure 6B) resulted in increased levels of the “comets” that belonged to groups 8 
and 9 (TM from 6.48 to 15.98). After radiation exposure at 46 h of incubation (Figure 6C), the 
increment of last three groups of “comets” (TM > 6.48) was observed.
It is noteworthy that γ-radiation exposure at 40 and 46 h of incubation did not cause decrease 
in the frequency of group 1, which includes the “comets” with the smallest DNA release into 
the “comet” tail (TM from 0 to 0.81). Probably, this situation reflects not so much on the exis-
tence in lymphocyte cultures of the populations of radiation-resistant and/or fully recovered 
cells, as the presence of heavily damaged cells in which the checkpoint has acted on the S 
phase of the cell cycle, because if the cells are in this phase, then significant decrease of DNA 
exit under the neutral conditions of electrophoresis is observed [35, 36]. This opinion is con-
firmed by the lack of increase in frequency of “comets” from the tenth group after radiation 
exposure at 40 h of cultivation: most of blast-transformed lymphocytes must be on S phase, 
and cells with the very high level of DNA damages cannot pass S/G
2
 checkpoint, and, as a 
result, they are delayed on this phase.
The supplementation with astaxanthin resulted in significant reduction in the levels of “com-
ets” that belonged only to the ten groups after irradiation at 0 (from 25.07 ± 2.25 to 8.96 ± 1.74%, 
p < 0.001) and at 46 h of cultivation (from 22.38 ± 1.77 to 10.45 ± 1.18%, p < 0.001) and groups 9 
and 10 after radiation exposure at 40 h of incubation (from 16.56 ± 1.72 to 6.69 ± 1.06, p < 0.001 
and from 8.60 ± 1.30 to 3.25 ± 0.75%, p < 0.01, respectively).
It is known that astaxanthin reveals apoptotic activity in experiments with different cultures 
of cancer cells [6, 33]. In our studies, the decrease in the frequency of highly damaged cells 
as a result of astaxanthin treatment may also be caused by activation of apoptotic processes.
The comet assay allowed not only estimating the relative level of DNA damages but also 
determining the intensity of apoptotic processes [37, 38]. For this purpose simultaneously 
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Figure 6. The frequency distribution of “comets” according to the relative levels of DNA damages (see explanation in 
the text) after irradiation at the 0th hour of cultivation (A), at the 40th hour of cultivation (B), and at the 46th hours of 
cultivation (C). Irr, irradiated in dose 1.0 Gy cultures; Irr + A, irradiated and supplemented with 20.0 μg/ml astaxanthin 
cultures. In one to ten groups of “comets,” 10% (bold line) is the control value for all groups [28].
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with the evaluation of the levels of DNA damages, the count of “atypical comets” (AC) 
(Figure 7) was carried out. It is obvious that AC were formed from the apoptotic cells, because 
the radiation dose we applied is quite low and cannot induce DNA fragmentation like this 
[39], while intensive DNA fragmentation occurs exactly during apoptosis [33].
In control cultures after 48 h of cultivation, the AC level was low and did not exceed 
1.45 ± 0.53%. The irradiation of lymphocyte cultures at the G
0
 stage of the cell cycle with 
further cultivation led to an increase in the frequency of AC from to 3.11 ± 0.71% (p < 0.05), 
but such effect was not observed after radiation exposure neither at the 40th hour nor at the 
46th hours of cultivation (Figure 7).
Astaxanthin in concentration of 20 μg/ml per se did not affect the amount of apoptotic cells 
in non-irradiated cultures of lymphocytes, but the AC level irradiated and treated by astax-
anthin cultures was approximately in four times higher than with 48-hour control (7.15 ± 1.13 
and 1.69 ± 0.56%, respectively, p < 0.01) and in two times higher than with irradiated samples 
(7.15 ± 1.13 and 3.57 ± 0.81%, respectively, p < 0.05). The increase in the frequency of apoptotic 
cells under the impact of astaxanthin was established exclusively in cultures irradiated at the 
G
0
 stage of the cell cycle and not observed after irradiation in other terms of cultivation.
Thus, similar to cytogenetic effect, the apoptotic activity of astaxanthin was detected only 
when the irradiated cells were on the G
0
 phase of the cell cycle. This may be the cause of the 
elimination of cells with a large number of DNA breaks and, as consequence, the reduction of 
the radiation-induced level of chromosomal aberrations we observed earlier.
Figure 7. The levels of “atypical comets” (AC%) in cultures of human lymphocytes after 48 hours of cultivation 
depending on the irradiation terms and the addition of astaxanthin. C, control cultures; A, supplemented with 20.0 μg/
ml astaxanthin cultures; 0, 40, and 46 h, cultures irradiated at the 0th, at the 40th, and at the 46th hours of cultivation, 
respectively; 0 h + A, 40 h + A, and 46 h + A, supplemented with 20.0 μg/ml astaxanthin cultures irradiated at the 0th, at 
the 40th, and at the 46th hours of cultivation, respectively.
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The absence of increase in the frequency of apoptosis after treatment in other terms of cul-
tivation both under the influence of only ionizing radiation and under the combined action 
of γ-radiation and astaxanthin can be explained by either insufficient time for realization of 
apoptosis or existence of contingent on the stage of the cell cycle apoptotic pathways, which 
astaxanthin is unable to activate on the S and G
2
 phases of the cell cycle.
Since the increase in the level of apoptosis is not a reason for the decline of the pool of high 
damaged cells under the astaxanthin influence after irradiation at 40 and 46 h of cultivation, 
the question remains: what is the cause of such effect of astaxanthin?
It is generally accepted that reactive oxygen species, which are formed by ionizing radiation 
exposure, cause DNA breaks [40]. Astaxanthin is a power antioxidant and capable to scav-
enge and quench free radicals and ipso facto to reduce the overall level of DNA damages [3]. 
According to the data presented in Figure 7, the results obtained after irradiation of cells at 
46 h of cultivation can be explained by the antioxidant properties of astaxanthin: reducing of 
oxidative stress leads to a decrease in the number of “comets” of the ten groups and increas-
ing (although not always statistically significant) in the frequencies of cells belonging to other 
groups (except 3 and 9).
However, such impact of astaxanthin was not observed when cells were irradiated at 40 h of 
cultivation. It is noteworthy that in this experiment the increase in the frequency of the “com-
ets” of group 1 (from 11.18 ± 1.46 to 17.54 ± 1.62%, p < 0.01) was detected. It can be explained by 
the fact that this group may include cells having a sufficiently large number of lesions enough 
to trigger mechanisms for the cell cycle arrest on the S phase. Probably, astaxanthin activates 
S-/G
2
-phase checkpoint that leads to an increase in the frequency of the cells from which the 
“comets” with low DNA are formed (by delay in S phase) and may cause decreasing in the 
frequency of the “comets” of groups 9 and 10. The results are consistent with the literature 
data concerning the effects of astaxanthin on the proliferation of tumor cells [7, 17, 41].
4. Conclusion
The obtained results enable us to resume the following astaxanthin effects on irradiated cells 
that may be clearly observed depending on the phase of the cell cycle and the duration of cells 
cultivation after irradiation:
1. Stimulation of apoptosis in the irradiated cells resulting in a decrease in the level of cells 
with a large number of DNA damages (irradiation on the G
0
 phase of the cell cycle and 
cultivation after irradiation for 48 h)
2. Stimulation of the processes that lead to the activation of the checkpoints on the S phase 
and, accordingly, arrest the division of the most damaged cell population (irradiation on 
the S phase of the cell cycle and cultivation after irradiation for 8 h)
3. Scavenge of reactive oxygen species resulting in reduction in the total level of DNA breaks 
(irradiation on the G
2
 phase of the cell cycle and cultivation after irradiation for 2 h)
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All of these effects are potentially radio- and genoprotective. However, we have previously 
shown that the protective action of astaxanthin concerning the radiation-induced cytoge-
netic effect similarly to its apoptotic effect was observed exclusively when irradiated cells 
were on the G
0
 phase of the cell cycle. Moreover, analyzing the ChA spectra (Figure 3), we 
found that supplementation with astaxanthin reduces exactly the levels of classic unstable 
cytogenetic markers of radiation exposure (dicentric and centric ring chromosomes), and it 
is known that the cells bearing unstable chromosomal aberrations are eliminated by apop-
tosis in the first place [42]. So, the radioprotective effect of astaxanthin rather may be due to 
its ability to stimulate apoptosis in cells that carry a subcritical number of DNA breaks than 
its potential genoprotective properties (defenses DNA from damages or activates of DNA 
repair processes).
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